Alphamab Oncology (HKG:9966)
7.85
+0.06 (0.77%)
Mar 6, 2026, 4:08 PM HKT
29.75% (1Y)
| Market Cap | 7.60B +111.2% |
| Revenue (ttm) | 861.24M +207.2% |
| Net Income | 255.11M |
| EPS | 0.26 |
| Shares Out | 968.57M |
| PE Ratio | 30.32 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,272,000 |
| Average Volume | 1,082,125 |
| Open | 7.79 |
| Previous Close | 7.79 |
| Day's Range | 7.78 - 8.02 |
| 52-Week Range | 4.86 - 15.75 |
| Beta | 0.40 |
| RSI | 35.25 |
| Earnings Date | Mar 27, 2026 |